These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8483323)

  • 81. Partial phenotypic reversion of HeLa cells by long-term interferon-alpha treatment.
    López Ocejo O; Perea SE; Reyes A; Vigoa L; López Saura P
    J Interferon Res; 1993 Oct; 13(5):369-75. PubMed ID: 8301158
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Close link between reduction of c-myc expression by interferon and, G0/G1 arrest.
    Einat M; Resnitzky D; Kimchi A
    Nature; 1985 Feb 14-20; 313(6003):597-600. PubMed ID: 3881681
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Protein factors that bind to the murine 2',5'-oligoadenylate synthetase ME-12 gene 5' upstream regulatory region.
    Yan C; Tamm I
    J Biol Chem; 1990 Nov; 265(33):20188-94. PubMed ID: 2243086
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Serum haptoglobin types and leukemia.
    Nevo S; Tatarsky I
    Hum Genet; 1986 Jul; 73(3):240-4. PubMed ID: 3460960
    [TBL] [Abstract][Full Text] [Related]  

  • 85. c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia.
    Lehn P; Sigaux F; Grausz D; Loiseau P; Castaigne S; Degos L; Flandrin G; Dautry F
    Blood; 1986 Oct; 68(4):967-70. PubMed ID: 3530350
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The chronic leukemias. Clinical picture, diagnosis, and management.
    Hurd DD
    Postgrad Med; 1983 May; 73(5):217-9, 222-7, 231. PubMed ID: 6573652
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Autogenous production of interferon-beta switches on HLA genes during differentiation of histiocytic lymphoma U937 cells.
    Yarden A; Shure-Gottlieb H; Chebath J; Revel M; Kimchi A
    EMBO J; 1984 May; 3(5):969-73. PubMed ID: 6376119
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Enhanced Antitumor Immune Response in 2'-5' Oligoadenylate Synthetase-Like 1- (OASL1-) Deficient Mice upon Cisplatin Chemotherapy and Radiotherapy.
    Sim CK; Lee JH; Baek IJ; Lee SW; Lee MS
    J Immunol Res; 2019; 2019():7596786. PubMed ID: 31049360
    [TBL] [Abstract][Full Text] [Related]  

  • 89. In vivo and In vitro interferon induction in chickens by S -28828, an imidazoquinolinamine immunoenhancer.
    Karaca K; Sharma JM; Tomai MA; Miller RL
    J Interferon Cytokine Res; 1996 Apr; 16(4):327-32. PubMed ID: 9162527
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Differential expression of selected genes in human leukemia leukocytes.
    Shiosaka T; Saunders GF
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4668-71. PubMed ID: 6956884
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Abdominal and pelvic computed tomography in leukemic patients.
    Geoffray A; Shirkhoda A; Wallace S
    J Comput Assist Tomogr; 1984 Oct; 8(5):857-60. PubMed ID: 6590576
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A model of skin inflammation in humans leads to a rapid and reproducible increase in the interferon response signature: a potential translational model for drug development.
    Dickson MC; Ludbrook VJ; Perry HC; Wilson PA; Garthside SJ; Binks MH
    Inflamm Res; 2015 Apr; 64(3-4):171-83. PubMed ID: 25596950
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Influence of alpha-interferon therapy on blood lymphoid cells. Studies on antibody production, mixed lymphocyte culture response, mitogen responsiveness and 2'-5'oligoadenylate synthetase activity.
    Einhorn S; Ling P; Einhorn N; Strander H; Wasserman J
    Cancer Immunol Immunother; 1987; 24(3):190-6. PubMed ID: 2954635
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lonidamine in the treatment of chronic lymphoid leukemia.
    Tura S; Cavo M; Gobbi M; Franchi P
    Oncology; 1984; 41 Suppl 1():90-3. PubMed ID: 6717903
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The familial occurrence of chronic lymphocytic leukemia and multiple myeloma.
    WIRTSCHAFTER SK; RAPAPORT SI
    Calif Med; 1960 Feb; 92(2):165-6. PubMed ID: 13845376
    [No Abstract]   [Full Text] [Related]  

  • 96. Chronic lymphocytic leukemia in China.
    Boggs DR; Chen SC; Zhang ZN; Zhang A
    Am J Hematol; 1987 Jul; 25(3):349-54. PubMed ID: 3605079
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Sensitive inhibitory effect of interferon-alpha on M-protein secretion of human myeloma cells.
    Tanaka H; Tanabe O; Iwato K; Asaoku H; Ishikawa H; Nobuyoshi M; Kawano M; Kuramoto A
    Blood; 1989 Oct; 74(5):1718-22. PubMed ID: 2790196
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Investigation of Expression Profile of Placenta-specific 1 (PLAC1) in Acute Myeloid and Lymphoid Leukemias.
    Gholami P; Asgarian-Omran H; Yaghmaie M; Mahmudian J; Kianersi S; Salari S; Zaboli E; Jeddi-Tehrani M; Zarnani AH; Shabani M
    Avicenna J Med Biotechnol; 2023; 15(3):167-172. PubMed ID: 37538244
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Chronic lymphocytic leukemia and multiple myeloma in husband and wife.
    Linet MS
    Am J Med Sci; 1984; 288(1):21-4. PubMed ID: 6465188
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Differential Expression of LMNA/C and Insulin Receptor Transcript Variants in Peripheral Blood Mononuclear Cells of Leukemia Patients.
    Alshaalan KS; Albawardi TK; Zhra M; Bin Sulaiman N; Jnied OY; Saleem RA; Aljada A
    J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.